Pulmonx (LUNG) Gross Profit (2019 - 2025)

Pulmonx (LUNG) has 7 years of Gross Profit data on file, last reported at $16.1 million in Q3 2025.

• Quarterly Gross Profit rose 6.83% year-over-year to $16.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $67.2 million (up 14.24% YoY) and the FY2024 annual result came in at $62.0 million, up 22.16% from the prior year.
• Gross Profit declined to $16.1 million in Q3 2025 per LUNG's latest filing, from $17.2 million in the prior quarter.
• Across five years, Gross Profit topped out at $17.6 million in Q4 2024 and bottomed at $6.6 million in Q1 2021.
• The 5-year median for Gross Profit is $12.7 million (2023), against an average of $12.5 million.
• The widest annual swing landed in 2021, when Gross Profit jumped 792.19%; it then climbed 4.24% in 2022.
• Tracing LUNG's Gross Profit over 5 years: stood at $10.3 million in 2021, then rose by 9.1% to $11.2 million in 2022, then advanced by 28.76% to $14.4 million in 2023, then grew by 22.15% to $17.6 million in 2024, then decreased by 8.74% to $16.1 million in 2025.
• Per Business Quant, the three latest LUNG Gross Profit figures stand at $16.1 million (Q3 2025), $17.2 million (Q2 2025), and $16.3 million (Q1 2025).

Peer Comparison